Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kairos Pharma (KAPA) Prepaid Assets (2024 - 2025)

Kairos Pharma's Prepaid Assets history spans 2 years, with the latest figure at $51000.0 for Q4 2025.

  • For Q4 2025, Prepaid Assets rose 34.21% year-over-year to $51000.0; the TTM value through Dec 2025 reached $51000.0, up 34.21%, while the annual FY2025 figure was $51000.0, 34.21% up from the prior year.
  • Prepaid Assets reached $51000.0 in Q4 2025 per KAPA's latest filing, down from $88000.0 in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $88000.0 in Q2 2025 to a low of $10000.0 in Q3 2024.